Literature DB >> 17256783

Cytotoxic T-cell-mediated defense against infections in human liver transplant recipients.

Koichi Tanaka1, Shinji Uemoto, Hiroto Egawa, Yasutsugu Takada, Kazue Ozawa, Satoshi Teramukai, Mureo Kasahara, Kohei Ogawa, Masako Ono, Hiroshi Sato, Kenji Takai, Masanori Fukushima, Kayo Inaba.   

Abstract

Previous studies have shown that postoperative infection is highest in transplant recipients with preexisting high levels of cytotoxic T lymphocytes (CTLs). To study this phenomenon, 106 adult liver transplant recipients were divided into 3 groups, based on hierarchical clustering of the CD3(+)CD8(+)CD45 isoform fractions prior to living donor liver transplantation (LDLT). Group I had the highest naive T-cell levels (subset CD45RO(-)CCR7(+)), Group II had the highest effector/memory (EM) T-cell levels (subset CD45RO(+)CCR7(-)), and Group III had the highest effector T-cell levels (subset CD45RO(-)CCR7(-)). In Group I, CTLs upregulated in response to invading pathogens much earlier and more rapidly than the other groups; this response was associated with CD4(+) T-cell help, downregulation of CD27(+)CD28(+) subsets, and upregulation of interferon-gamma and perforin expression. In contrast, in Groups II and III, CTLs upregulated slowly following persistent viral infection and did not respond efficiently to acute infection. In addition, Group II's cytolytic responses were due mainly to upregulation of the CD8(+) EM T-cell fraction, whereas Group III's cytolytic responses were attributable to upregulation of effector T cells. The prevalence of EM or effector T cells was dependent on differentiation of the CD8(+) phenotype before LDLT. In conclusion, in most infected transplant recipients who died, generation of CD8(+) CTLs had been suppressed without associated CD4(+) T-cell help. (c) 2007 AASLD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17256783     DOI: 10.1002/lt.21065

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  3 in total

1.  Advantage of tacrolimus/mycophenolate mofetil regimen for cytotoxic T cell-mediated defence and its inhibition by additive steroid administration in high-risk liver transplant recipients.

Authors:  S Uemoto; K Ozawa; T Kaido; A Mori; Y Fujimoto
Journal:  Clin Exp Immunol       Date:  2016-01-11       Impact factor: 4.330

2.  Serial assessment of immune status by circulating CD8 effector T cell frequencies for posttransplant infectious complications.

Authors:  Shinji Uemoto; Kazue Ozawa; Hiroto Egawa; Yasutsugu Takada; Hiroshi Sato; Satoshi Teramukai; Mureo Kasahara; Kohei Ogawa; Masako Ono; Kenji Takai; Masanori Fukushima; Kayo Inaba; Koichi Tanaka
Journal:  Clin Dev Immunol       Date:  2008

3.  Impact of preexisting circulating effector T cells on the outcome of ABO-incompatible adult LDLT.

Authors:  Hiroto Egawa; Kazue Ozawa; Yasutsugu Takada; Satoshi Teramukai; Akira Mori; Mureo Kasahara; Kohei Ogawa; Yasuhiro Ogura; Fumitaka Oike; Toshimi Kaido; Masako Ono; Hiroshi Sato; Kenji Takai; Shinji Uemoto
Journal:  Dig Dis Sci       Date:  2008-12-11       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.